Holding(s) in Company

RNS Number : 3016O
Port Erin Biopharma Investments Ltd
15 September 2011
 



 




TR-1 : NOTIFICATION OF MAJOR INTEREST IN SHARESi



1. Identity of the issuer or the underlying issuer
of existing shares to which voting rights are
attached:
ii

PORT ERIN BIOPHARMA

2 Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached


An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments


An event changing the breakdown of voting rights


Other (please specify):


3. Full name of person(s) subject to the
notification obligation:
iii

CITY EQUITIES LIMITED

4. Full name of shareholder(s)
 (if different from 3.):iv


5. Date of the transaction and date on
which the threshold is crossed or
reached:
v

15 SEPTEMBER 2011 PLACING PARTICIPATION

15 SEPTEMBER 2011 ADMISSION TO AIM

6. Date on which issuer notified:

15 SEPTEMBER 2011

7. Threshold(s) that is/are crossed or
reached:
vi, vii

ABOVE 4% TO BELOW 3%



 

8. Notified details:

A: Voting rights attached to shares viii, ix

Class/type of
shares


if possible using
the ISIN CODE

Situation previous
to the triggering
transaction

Resulting situation after the triggering transaction

Number
of
Shares

Number
of
Voting
Rights

Number
of shares

Number of voting
rights

% of  voting rights x

Direct

Direct xi

Indirect xii

Direct

Indirect

 

 

IM00B6QH1J21

1,500,000

1,500,000

NIL

NIL

NIL

NIL

NIL



B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financial
instrument

Expiration
date
xiii

Exercise/
Conversion Period
xiv

Number of voting
rights that may be
acquired if the
instrument is
exercised/ converted.

% of voting
rights







C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi

Resulting situation after the triggering transaction

Type of financial
instrument

Exercise price

Expiration date xvii

Exercise/
Conversion period
xviii

Number of voting rights instrument refers to

 

% of voting rights xix, xx

 





 

 

Nominal

Delta




Total (A+B+C)

Number of voting rights

Percentage of voting rights

NIL

NIL



 

9. Chain of controlled undertakings through which the voting rights and/or the
financial instruments are effectively held, if applicable:
xxi

 

 


Proxy Voting:

10. Name of the proxy holder:


11. Number of voting rights proxy holder will cease
to hold:


12. Date on which proxy holder will cease to hold
voting rights:




13. Additional information:


Shares acquired in the Company's Placing, announced on 15 September 2011. Shares have been sold to certain clients, with City Equities Limited acting as Principal.

 

14. Contact name:

WENYI LIU

15. Contact telephone number:

02074895562



 

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLLAMMTMBBBBTB
UK 100

Latest directors dealings